Tenders Are Invited For Pharmaceutical Products-Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicines With The Active Ingredient Amifampridine (Atc Code: N07xx05).

Pharmaceutical Products-Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicines With The Active Ingredient Amifampridine (Atc Code: N07xx05).. The Aok Lower Saxony. Until The Entry Into Force Of Exclusive Contracts According To A Public Tender, The Health Insurance Company Intends Not Exclusive Pharmaceutical Discounts On The Active Ingredient Amifampridin (Atc-Code: N07xx05) With All Market Participants (Pharmaceutical Entrepreneurs Or Communities As Possible) . The Aok Lower Saxony Will Not Make A Selection Decision And Will Submit An Identical Contract Offer To Any Interested Pharmaceutical Company. In The Open House Model, Uniform Conditions Apply To All Participants. Contract Content, Conditions And Access Procedures Are Uniform - Individual Negotiations Are Generally Not Conducted. The Contract Term Is A Maximum Of Twenty -Four Months, The Earliest Start Of The Contract Is 01.04.2025. All Contracts End On March 31, 2027 At The Latest, Regardless Of The Date Of The Respective Contract. Entrance Or A Contract Can Be Concluded Within The Twenty -Four -Month Period For The First Of A Month. There Is A Right Of Termination For Six Weeks At The End Of The Month. Aok Lower Saxony Reserves The Right To Replace The Non-Exclusive Open House Discount Contracts With Exclusive Discount Contracts During The Contract Period. With The Entry Into Force, The Exclusive Discount Contracts Are Terminated By The Open House Contracts In Accordance With The Contractual Regulation. H. The Open House Contracts Automatically End. The Experience Of The Aok Niedersachsen After Exclusive Discount Contracts Generally Come Into Force Six To Eight Months After The Publication Of The Corresponding Announcement In The Supplement To The Official Journal Of The European Union. The Future Contractual Partners In The Open House Model Are Asked To Regularly Find Out More In The Supplement To The Official Journal Of The European Union With Regard To These Announcements. Interested Pharmaceutical Companies Can Request The Contract Documents And The Contractual Conditions Under The Contact Address Mentioned Under I.1). Contracts For The Active Ingredient Amifampridine (Atc Code: N07xx05) Are Concluded For The First Time With Effect On 01.04.2025. Interested Parties Who Would Like To Become A Contractual Partner For This Date Must Submit The Contract Documents To Be Submitted By 25.02.2025 At The Address Mentioned In The Contract Documents. It Depends On Access To The Aok Lower Saxony. Later Conclusions Are Possible For The First One Month During The Twenty -Four -Month Maximum Term. Organizationally, A Preliminary Run Of 35 Calendar Days On The Part Of The Aok Is Necessary In Order To Do The Necessary Work, E.G. B. To Be Able To Guarantee The Contract Report In The Lauer-Taxe®. The Exact Entrance Periods Will Be Announced With The Contract Documents. Deals With The Present Publication